Journal Mobile Options
Table of Contents
Vol. 17, No. 5, 2012
Issue release date: August 2012
Audiol Neurotol 2012;17:321–330

A Case Series of Paediatric Hearing Preservation Cochlear Implantation: A New Treatment Modality for Children with Drug-Induced or Congenital Partial Deafness

Kuthubutheen J. · Hedne C.N. · Krishnaswamy J. · Rajan G.P.
aDepartment of Otolaryngology, Head and Neck Surgery, Fremantle Hospital, Fremantle, W.A., bAudiology Department, School of Medicine, University of Western Australia, Princess Margaret Hospital for Children, Subiaco, W.A., and cDepartment of Otolaryngology, Head and Neck Surgery, School of Surgery, University of Western Australia, Nedlands, W.A., Australia

Individual Users: Register with Karger Login Information

Please create your User ID & Password

Contact Information

I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in


Objective: To investigate the use of hearing preservation cochlear implantation in children with partial deafness. Patients and Methods: Five children with either drug-induced or congenital partial deafness were enrolled in a pilot study. The patients ranged in age from 13 months to 14 years. Implantation was performed using a hearing preservation technique. A Flex EAS electrode (MED-EL, Innsbruck, Austria) was used in all full insertions. Results: Low frequency hearing was preserved in all patients with postoperative bone conduction within 10 dB of the preoperative hearing levels. These changes were preserved over the follow-up period of 12 months. There were significant improvements in speech perception. Conclusion: Hearing preservation cochlear implantation is a new effective modality in children with partial deafness.

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.


  1. Bodmer D, Brors D, Pak K, Bodmer M, Ryan AF: Gentamicin-induced hair cell death is not dependent on the apoptosis receptor Fas. Laryngoscope 2003;113:452–455.
  2. Clark GM, Black R, Dewhurst DJ, Forster IC, Patrick JF, Tong YC: A multiple-electrode hearing prosthesis for cochlea implantation in deaf patients. Med Prog Technol 1977;5:127–140.
  3. Dorman MF, Gifford RF: Combining acoustic and electric stimulation in the service of speech recognition. Int J Audiol 2010;49:912–919.

    External Resources

  4. Fraysse B, Macías AR, Sterkers O, Burdo S, Ramsden R, Deguine O, Klenzer T, Lenarz T, Rodriguez MM, Von Wallenberg E, James C: Residual hearing conservation and electroacoustic stimulation with the nucleus 24 contour advance cochlear implant. Otol Neurotol 2006;27:624–633.
  5. Gantz BJ, Hansen MR, Turner CW, Oleson JJ, Reiss LA, Parkinson AJ: Hybrid 10 clinical trial: preliminary results. Audiol Neurootol 2009;14(suppl 1):32–38.
  6. Gifford RH, Dorman MF, Brown CA: Psychophysical properties of low-frequency hearing: implications for perceiving speech and music via electric and acoustic stimulation. Adv Otorhinolaryngol 2010;67:51–60.
  7. Gstoettner W, Kiefer J, Baumgartner WD, Pok S, Peters S, Adunka O: Hearing preservation in cochlear implantation for electric acoustic stimulation. Acta Otolaryngol 2004;124:348–352.
  8. Gstoettner WK, van de Heyning P, O’Connor AF, Morera C, Sainz M, Vermeire K, Mcdonald S, Cavallé L, Helbig S, Valdecasas JG, Anderson I, Adunka OF: Electric acoustic stimulation of the auditory system: results of a multi-centre investigation. Acta Otolaryngol 2008;128:968–975.
  9. Gstoettner W, Helbig S, Settevendemie C, Baumann U, Wagenblast J, Arnoldner C: A new electrode for residual hearing preservation in cochlear implantation: first clinical results. Acta Otolaryngol 2009;129:372–379.
  10. Hochmair ES, Hochmair-Desoyer IJ, Burian K: Experience with implanted auditory nerve stimulator. Trans Am Soc Artif Intern Organs 1979;25:357–361.
  11. House WF: The clinical value of single electrode systems in auditory prostheses. Otolaryngol Clin North Am 1978;11:201–208.
  12. Kiefer J, Pok M, Adunka O, Stürzebecher E, Baumgartner W, Schmidt M, Tillein J, Ye Q, Gstoettner W: Combined electric and acoustic stimulation of the auditory system: results of a clinical study. Audiol Neurootol 2005;10:134–144.
  13. Nadol JB Jr, Eddington DK: Treatment of sensorineural hearing loss by cochlear implantation. Annu Rev Med1988;39:491–502.

    External Resources

  14. Niparko JK, Tobey EA, Thal DJ, Eisenberg LS, Wang NY, Quittner AL, Fink NE: Spoken language development in children following cochlear Implantation. JAMA 2010;303:1498–1506.
  15. Prentiss S, Sykes K, Staecker H: Partial deafness cochlear implantation at the University of Kansas: techniques and outcomes. J Am Acad Audiol 2010;21:197–203.

    External Resources

  16. Rajan GP, Kuthubutheen J, Hedne N, Krishnaswamy J: The role of preoperative, intratympanic glucocorticoids for hearing preservation in cochlear implantation: a prospective clinical study. Laryngoscope 2012;122:190–195.
  17. Skarzyński H, Lorens A, D’Haese P, Walkowiak A, Piotrowska A, Sliwa L, Anderson I: Preservation of residual hearing in children and post-lingually deafened adults after cochlear implantation: an initial study. ORL J Otorhinolaryngol Relat Spec 2002;64:247–253.
  18. Skarzynski H, Lorens A, Piotrowska A, Anderson I: Partial deafness cochlear implantation provides benefit to a new population of individuals with hearing loss. Acta Otolaryngol 2006;126:934–940.
  19. Skarzynski H, Lorens A, Piotrowska A, Anderson I: Partial deafness cochlear implantation in children. Int J Pediatr Otorhinolaryngol 2007;71:1407–1413.
  20. Skarzynski H, Lorens A, Piotrowska A, Anderson I: Preservation of low frequency hearing in partial deafness cochlear implantation (PDCI) using the round window surgical approach. Acta Otolaryngol 2007;127:41–48.
  21. Turner CW, Gantz BJ, Karsten S, Fowler J, Reiss LA: Impact of hair cell preservation in cochlear implantation: combined electric and acoustic hearing. Otol Neurotol 2010;31:1227–1232.

    External Resources

  22. Usami S, Moteki H, Suzuki N, Fukuoka H, Miyagawa M, Nishio SY, Takumi Y, Iwasaki S, Jolly C: Achievement of hearing preservation in the presence of an electrode covering the residual hearing region. Acta Otolaryngol 2011;131:405–412.

    External Resources

  23. von Ilberg C, Kiefer J, Tillein J, Pfenningdorff T, Hartmann R, Stürzebecher E, Klinke R: Electric-acoustic stimulation of the auditory system. New technology for severe hearing loss. ORL J Otorhinolaryngol Relat Spec 1999;61:334–340.
  24. Wilson BS, Lawson DT, Finley CC, Wolford RD: Coding strategies for multichannel cochlear prostheses. Am J Otol1991;12(suppl):56–61.
  25. Zhang T, Dorman MF, Spahr AJ: Information from the voice fundamental frequency (F0) region accounts for the majority of the benefit when acoustic stimulation is added to electric stimulation. Ear Hear 2010;31:63–69.

    External Resources

Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50